Last reviewed · How we verify
NCT06212726
RTL Concussion Communication
NA trial testing InjureFree in Concussion, Mild. Withdrawn.
15 June 2026
Quick facts
| Lead sponsor | University of Florida |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Start date | 28 August 2024 |
| Primary completion | 15 June 2026 |
| Estimated completion | 30 August 2026 |
Drugs / interventions tested
- InjureFree
Conditions studied
- Concussion, Mild — all drugs for Concussion, Mild →
- Post Concussion Symptoms — all drugs for Post Concussion Symptoms →
- Cognitive Impairments — all drugs for Cognitive Impairments →
- Cognitive Impairments, Mild — all drugs for Cognitive Impairments, Mild →
Sponsor
University of Florida
Who can join
Adults 14 to 19, any sex, with Concussion, Mild or Post Concussion Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is aimed at improving health outcomes for adolescents who sustain sport and recreation related concussions (SRRC) by enhancing Return to Learn (RTL). The study will conduct a quasi-experimental school-based 2 phase study involving 200 students with SRRC. The first phase will be descriptive to evaluate current standards (n=50). Phase 2 will compare students whod receive either standard of care RTL (n=75) or RTL augmented by a communication tool (RTC+; n=75).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06212726
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Concussion, Mild
Currently open trials in the same condition.
- NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
- NCT06559865 — Impact of a Paced Breathing Exercise Intervention on Autonomic Nervous System Function After Pediatric Concussion · NA · recruiting
- NCT06105892 — Eye Recovery Automation for Post Injury Dysfunction (iRAPID) · NA · recruiting
- NCT05857761 — GAIN Symptoms: Post-traumatic Headache · NA · active not recruiting
Other University of Florida trials
Trials by the same sponsor.
- NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
- NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
- NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
- NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
- NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06212726 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Florida
- Last refreshed: 23 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06212726.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing